Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

When treating anal squamous cell carcinoma, how does your radiotherapy regimen change when there is a bleeding anal fissure?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Washington University School of Medicine

I wouldn't delay tx. The simple non-surgical things used to try to manage an anal fissure (Metamucil, warm water soaks, and a topical cream like Anusol) also help to get a patient through the acute effects of RT. I would be very uncomfortable with any surgical attempts to manage the fissure. Cutting...

What is your bladder constraint for LDR prostate brachy?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Medical University of South Carolina

There are typically no bladder constraints with LDR planning. The bladder itself should generally not be in the PTV. The urethra does have important planning objectives/constraints, which depend on isotope and technique used. ABS guidelines are a good place to start. Some people do have loose constr...

Would you give/omit regional nodal irradiation in low nodal burden ER- Her2+ disease s/p BCS with SLNB?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

When I evaluate patients in this situation, BCS + SLN with positive node, I tend to think about the decision as to the whole breast RT+/- RNI and use AMAROS/Z011 to frame my decision making.In an ER-negative patient, I would favor RNI, extrapolating from MA20 (where patients had an ALND, and 85% 1-3...

For a patient with oligometastatic breast cancer that has completed adequate local therapy, would you consider ablating synchronous oligometastatic disease?

3
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

The prospective studies which are conducted for locoregional treatment for synchronous metastases didn't include treating metastatic disease with SABR. In practice, if we go the route of LRT in select subset, then consider SABR also, if still visible after systemic treatment.

Is there any role for differential cardiac substructure dose tolerances when treating with radiation for breast cancer?

3
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

There is growing literature on the role of defining cardiac substructures and potential dosimetric constraints for these substructures as an improved methodology for cardiac DVH assessment, as compared to mean heart dose (Jacob et al., PMID 30732640).However, at this time, we do not have robust long...

In the treatment of recurrent trigeminal neuralgia, what local therapy would you recommend after failure of medical therapy?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Washington School of Medicine

I will recommend surgery (microvascular decompression) only when there is a surgically fixable abnormality, such as vascular compression. In that case, microvascular decompression is more effective than SRS. Otherwise, I will offer SRS, which can be offered twice targeting a root entry zone and a mo...

Would you offer radiation alone to localized recurrence of extensive stage small cell lung cancer while on maintenance immunotherapy or would you start alternative systemic therapy?

2
1 Answers

Mednet Member
Mednet Member
Medical Oncology · Indiana University School of Medicine

The role of local therapy for the treatment of patients with ES SCLC has been evaluated in a number of phase 3 trials. The first trial, which was published by Jeremic et al., PMID 10561263 over 20 years ago, reported a survival advantage for adding thoracic radiation to chemotherapy compared with ch...

What small bowel dose constraints do you use when treating with short course radiation for rectal cancer?

5
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Henry Ford Health System

In my experience, I have set a small bowel max of 25 Gy; sometimes allowing up to 27 Gy. This was out of an abundance of caution; our initial experience (1) was with 20 Gy/5 fractions and there was concern about increasing the radiation dose to 25 Gy. Also, we wanted to make sure that patients with ...

What do you tell men with low but detectable PSA who have completed ADT and RT?

4
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Beth Israel Deaconess Medical Center/Harvard Medical School

Several analysis have shown that patients who do not achieve undetectable PSA levels after 6 months of ADT have worse outcomes. This is a bit of a moving target and the definition of undetectable has changed over the decades. An important question is - are these patients failing due to incomplete lo...

What is the role of radiation in a patient with stage IV DLBCL with bilateral testicular involvement?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Cincinnati

I tend to loosely recommend consolidation RT to the testicles in this situation if in CR. This recommendation is based on pattern-of-failure studies in primary testicular lymphoma where prophylactic contralateral testes RT is usually recommended, and the principle that the testicles are a sanctuary ...